Clinical/scientific notes

Neurology

Volumn 78, Issue 12, 2012, Pages 928-930

  Castrop, F ^a   Kowarik, M C ^a   Albrecht, H ^b   Krause, M ^b   Haslinger, B ^a   Zimmer, C ^a   Berthele, A ^a   Hemmer, B ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Neurologic Office   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; FINGOLIMOD; LIVER ENZYME; BETA1A INTERFERON; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; NATALIZUMAB; PROPANEDIOL DERIVATIVE; SPHINGOSINE;

ADULT; ARTICLE; CASE REPORT; DISEASE SEVERITY; DRUG SAFETY; DRUG WITHDRAWAL; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; RELAPSE; REMISSION; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME; ATAXIA; BRAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PLASMAPHERESIS; RECURRENT DISEASE; SPINE;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ATAXIA; BRAIN; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-BETA; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PLASMA EXCHANGE; PROPYLENE GLYCOLS; RECURRENCE; SPHINGOSINE; SPINE;

EID: 84860344893     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31824c46ad     Document Type: Article

References (3)

1. Schwab SR, Cyster JG. Finding a way out: Lymphocyte egress from lymphoid organs. Nat Immunol 2007;8: 1295-1301. (Pubitemid 350131168)
2. Wolf AM, Eller K, Zeiser R, et al. The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo. J Immunol 2009;183:3751-3760.
3. Sawicka E, Dubois G, Jarai G, et al. The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4/CD25 T-regulatory cells and enhances their functional activity. J Immunol 2005; 175:7973-7980. (Pubitemid 41798358)